13 analysts have shared their evaluations of TransMedics Gr (NASDAQ:TMDX) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 8 | 1 | 0 | 0 |
| Last 30D | 0 | 0 | 0 | 0 | 0 |
| 1M Ago | 2 | 2 | 1 | 0 | 0 |
| 2M Ago | 2 | 4 | 0 | 0 | 0 |
| 3M Ago | 0 | 2 | 0 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $133.62, with a high estimate of $200.00 and a low estimate of $104.00. This current average represents a 20.15% decrease from the previous average price target of $167.33.
Diving into Analyst Ratings: An In-Depth Exploration
In examining recent analyst actions, we gain insights into how...
Login or create a forever free account to read this news
Sign up/Log in
